You may think that with a price-to-sales (or “P/S”) ratio of 5.8x Quick Heal Technologies Limited (NSE:QUICKHEAL) is a stock to potentially avoid, seeing as almost half of all the Software companies in India have P/S ratios under 4.4x and even P/S lower than 1.7x aren’t out of the ordinary. Nonetheless, we’d need to dig a little deeper to determine if there is a rational basis for the elevated P/S.

Trump has pledged to “unleash” American oil and gas and these 15 US stocks have developments that are poised to benefit.

See our latest analysis for Quick Heal Technologies

What Does Quick Heal Technologies’ Recent Performance Look Like?

As an illustration, revenue has…